Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
125 hedge funds and large institutions have $212M invested in Arena Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 7 closing their positions.
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
47% more call options, than puts
Call options by funds: $1.37M | Put options by funds: $931K
26% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 35
5% more funds holding
Funds holding: 119 → 125 (+6)
4% more capital invested
Capital invested by funds: $203M → $212M (+$8.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.21M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$766K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$642K |
| 4 |
Millennium Management
New York
|
+$581K |
| 5 |
State Street
Boston,
Massachusetts
|
+$477K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.92M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$389K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$247K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$233K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$178K |
ARNA Hedge Fund Activity: Q3 2016 in Review
125 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2016, worth a combined $212M — up 4% from $203M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ARNA positions and 7 closed out — a net gain of 7 holders — while 44 added to existing stakes and 35 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.21M. The largest seller was Wellington Management Group, cutting an estimated $1.92M.
- 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2016, up from 119 in Q2 2016.
- Funds reported $212M of Arena Pharmaceuticals Inc stock for Q3 2016, up 4% quarter-over-quarter.
- 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2016 and 7 closed out, a net change of +7 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $2.21M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2016 was Wellington Management Group, an estimated $1.92M sold.
Based on aggregated 13F filings for Q3 2016.